Natural cannabinoids exist as specific stereoisomers and synthetic routes often produce racemic mixtures or incorrect chiral forms. Achieving high optical purity is essential for consistent therapeutic efficacy and regulatory compliance.

Crude cannabinoid mixtures contain unwanted chemical artifacts and inconsistent ratios. Eliminating these impurities ensures standardized potency and safety for downstream applications.